EPCAM and oral cavity squamous cell carcinoma: In the present study, an attempt has been made to study the expression of EGP40 (Ep-CAM) on different grades of oral squamous cell carcinoma (OSCC) which may contribute towards immunopathological diagnosis, in the development of new therapeutic strategies by employing this antigen as a target.